Lutetium Lu-177 Vipivotide Tetraxetan vs Trastuzumab

## Lutetium Lu-177 Vipivotide Tetraxetan vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Lutetium Lu-177 Vipivotide Tetraxetan** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Lutetium Lu-177 Vipivotide Tetraxetan — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Lutetium Lu-177 Vipivotide Tetraxetan — Protein; Trastuzumab — Antibody.